छोड़कर सामग्री पर जाएँ

BDR Pharmaceutical launches generic drug for treating prostate cancer in India

The drug has been launched under the brand APATIDE in India to treat both metastatic castration sensitive prostate cancer as well as non-metastatic castration resistant prostate cancer.

Read More

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी